Viridian Therapeutics Inc (VRDN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | VRDN | TARS | VERA | ||
| Company | Viridian Therapeutics Inc | Tarsus Pharmaceuticals Inc | Vera Therapeutics Inc Cl A | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 27.86 | 67.01 | 39.88 | ||
| High | 28.18 | 68.86 | 40.47 | ||
| Low | 27.29 | 66.09 | 38.17 | ||
| Latest | 27.39 | 66.25 | 38.86 | ||
| Change | -0.81 | -0.95 | -1.40 | ||
| % Change | -2.87% | -1.41% | -3.48% | ||
| Volume | 1,413,400 | 352,400 | 763,100 | ||
| 20-Day Average Volume | 1,337,130 | 501,805 | 1,319,755 | ||
| Previous Close | 28.20 | 67.20 | 40.26 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 28.52 | 69.89 | 39.95 | ||
| 20-Day Raw Stochastic | 24.70% | 28.40% | 17.16% | ||
| 20-Day Relative Strength | 43.08 | 44.67 | 43.33 | ||
| Weighted Alpha | +80.09 | +26.72 | +36.59 | ||
| Today's Opinion | 8% Sell | 24% Sell | 8% Buy | ||
| Previous Opinion | 8% Sell | 24% Sell | 24% Buy | ||
| Last Month's Opinion | 40% Buy | 56% Buy | 40% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.52% since 03/20/26 | +2.70% since 03/20/26 | -4.12% since 03/20/26 | ||
| Low | 26.27 on 03/24/26 | 61.51 on 03/24/26 | 38.17 on 03/27/26 | ||
| High | 28.59 on 03/25/26 | 68.86 on 03/27/26 | 42.25 on 03/23/26 | ||
| 1-Month | |||||
| %Chg | -6.77% since 02/27/26 | -12.27% since 02/27/26 | -4.73% since 02/27/26 | ||
| Low | 26.27 on 03/24/26 | 61.51 on 03/24/26 | 37.51 on 03/19/26 | ||
| High | 30.79 on 03/05/26 | 78.20 on 03/04/26 | 45.38 on 03/10/26 | ||
| 3-Month | |||||
| %Chg | -14.08% since 12/26/25 | -18.99% since 12/26/25 | -27.47% since 12/26/25 | ||
| Low | 26.27 on 03/24/26 | 60.54 on 02/13/26 | 37.51 on 03/19/26 | ||
| High | 34.29 on 01/14/26 | 83.94 on 12/31/25 | 53.76 on 12/29/25 | ||
| 6-Month | |||||
| %Chg | +35.66% since 09/26/25 | +17.69% since 09/26/25 | +37.80% since 09/26/25 | ||
| Low | 19.93 on 09/29/25 | 55.90 on 09/29/25 | 23.05 on 11/06/25 | ||
| High | 34.29 on 01/14/26 | 85.25 on 12/09/25 | 56.05 on 12/24/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 2,799,450 | 2,819,401 | 2,772,895 | ||
| Shares Outstanding, K | 102,207 | 42,557 | 71,356 | ||
| Annual Sales | 70,850,000 | 451,360,000 | 0 | ||
| Annual Net Income | -342,600,000 | -66,420,000 | -299,610,000 | ||
| Last Quarter Sales | 130,000 | 151,670,000 | 0 | ||
| Last Quarter Net Income | -120,360,000 | -8,370,000 | -91,100,000 | ||
| 60-Month Beta | 1.00 | 0.55 | 1.17 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.08 on 02/26/26 | -0.20 on 02/23/26 | -1.39 on 02/26/26 | ||
| Latest Earnings Date | 05/05/26 | 05/07/26 | 05/05/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||